The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could ...

Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

People taking semaglutide drugs like Ozempic typically expect to lose excess weight — not hair. But that’s precisely what happened to Desiree Rodriguez, who has been sharing her journey on ...

A Fremont business owner was arrested on March 12 and charged with prescribing prescription drugs without a license and ...

A similar prohibition on copycat weight loss medications that contain the active ingredient semaglutide is scheduled to take effect as early as April 22. The FDA announced the updated guidance ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular ...